US Is Home to More Than 18 Million Cancer Survivors
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.
Endocrine Cancer
Bridge Therapy Between Induction, ASCT May Slow Neuroblastoma
Bridging therapy before ASCT improved event-free survival for patients with stable metastatic disease at the end of induction.
Hispanic Children With High-Risk Neuroblastoma Have Worse Outcomes
Hispanic children had inferior overall survival despite receiving the same treatment as their peers.
Molecular Profiling Can Guide Treatment After Recurrence in Young Cancer Patients
Nearly 70% of patients had at least 1 potentially actionable therapeutic target.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Risk of Breakthrough COVID-19 Varies by Cancer Type
The risk of breakthrough SARS-CoV-2 infections was highest for liver cancer and lowest for thyroid cancer.
Pandemic Tied to Drop in New Cancer Diagnoses
At the start of the pandemic, there was an immediate 34.3% decline in the estimated mean cancer incidence volume.
Radioiodine Provides No Benefit After Thyroidectomy in Low-Risk Thyroid Cancer
Radioiodine after thyroidectomy did not improve outcomes in patients with low-risk thyroid cancer.
Peptide Receptor Radionuclide Therapy Prolongs PFS in Enteropancreatic Neuroendocrine Tumors
When compared with chemotherapy or targeted therapy, peptide receptor radionuclide therapy significantly prolonged progression-free survival.
Exploring a Potential Link Between Children With Obesity and Thyroid Cancer
Researchers hypothesized that a rising number of thyroid cancer rates in adults with obesity in may also imply an increase in thyroid cancer rates in children.
- Loading...
Loading...
Next post in Endocrine Cancer
Loading... 
Loading...